3Enelow RI, Mohammed AZ, Stoler MH, et al. Structural and functional consequences of alveolar cell recognition by CD8+T lymphocytes in experimental lung disease [J].J Clin Invest. 2008, 112: 1653-1661.
2[1]Jacobsson LTH,Axell TE,Hansen BU,et al.Dry eyes and mouth:an epidemiological study in Sweden adult,with special reference to primary Sj gren's syndrome[J].J Autoimmun,1989,2:521.
3[2]Tsubota K,Hirai S,King LS,et al.Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjgren's syndrome[J].Lancet,2001,357(9257):688-689.
4[3]Hulkkonen J,Pertovaara M,Kantonen J,et al.Genetic association between interleukin-10 promoter region polymorphisms and primary sjogren's syndrome[J].Arthritis Rheum,2001,44(1):176-179.
5[4]Witte T,Matthias T,Arnett FC,et al.IgA and IgG autoantibodies against α-Fodrin as markers for SS[J].J Rheumatol,2000,27(11):2617-2620.
6[6]Zhu Z,Stevenson D,Schechter JE,et al.Prophylactic effect of IL-10 gene transfer on induced autoimmune dacryoadenitis[J].Invest Ophthalmol Vis Sci,2004,45(5):1375-1381.
7[7]Koski H,Janin A,Humphreys-Beher MG,et al.Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjogren's syndrome[J].Clin Exp Rheumatol,2001,19(2):131-137.
8[8]Pijpe J,Imhoff GW,Spijkervet FK,et al.Rituximab treatment in patients with primary Sjogren's syndrome:an open-label phase Ⅱ study[J].Arthritis Rheum,2005,52(9):2740-2750.
9[9]Epratuzumab Steinfeld SD,Tant L,Burmester GR,et al.(humanised anti-CD22 antibody) in primary Sjogren's syndrome:an open-label phase Ⅰ/Ⅱ study[J].Arthritis Res Ther,2006,8(4):129.
10[10]Mariette X,Ravaud P,Steinfeld S,et al.Inefficacy of infliximab in primary Sjogren's syndrome:results of the randomized,controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS)[J].Arthritis Rheum,2004,50(4):1270-1276.
3Zhao X, Chen J, Ye L, et al. Serum metabolomics study of the acute graft rejection in human renal transplantation based on liquid chromatography-mass spectrometry [J]. Proteome Res, 2014,13(5) :2659-2667.
4Cobbold SP, Graca L, Lin CY, et aI. Regnlatory T ceils in the induction and maintenance of peripheral transplantation tolerance [J]. Transpl Int,2003,16(2) :66-75.
5Degauque N, Lair D, Dupont A, et al. Dominant tolerance to kidney allografts induced by anti donor MHC class II antibodies: cooperation between T and non-T CD103+ cells[J].Immunol, 2006,176 (7):3915-3922.
6Higo S, Shimizu A, Masuda Y, et aL Acute graft-versus-host disease of the kidney in allogeneie rat bone marrow transplantation[J]. PLoS One,2014,9(12) :e115399.
7Ducloux D, Courivaud C, Bamoulid J, et al. Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation[J]. Am Soc Nephrol, 2010,21 (5) : 868-875.
8Issa F, Schiopu A, Wood KJ. Role of T cells in graft rejection and transplantation tolerance[J]. Expert Rev Clln Immunol, 2010,6(1) : 155-169.
